Related references
Note: Only part of the references are listed.Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity
Chen Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Diagnostic usefulness of molecular detection of Coxiella burnetii from blood of patients with suspected acute Q fever
Moonsuk Bae et al.
MEDICINE (2019)
Comparison of PCR and Viable Count as a Method for Enumeration of Bacteria in an A/J Mouse Aerosol Model of Q Fever
M. Gill Hartley et al.
FRONTIERS IN MICROBIOLOGY (2019)
From cell culture to cynomolgus macaque: infection models show lineage-specific virulence potential of Coxiella burnetii
Georgina Metters et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
From Q Fever to Coxiella burnetii Infection: a Paradigm Change
Carole Eldin et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
A human time dose response model for Q fever
Charles W. Heppell et al.
EPIDEMICS (2017)
Kinetics of antibody response to Coxiella bumetii infection (Q fever): Estimation of the seroresponse onset from antibody levels
C. C. H. Wielders et al.
EPIDEMICS (2015)
Efficacy of Liposome-Encapsulated Ciprofloxacin in a Murine Model of Q Fever
I. H. Norville et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Q fever in the Netherlands-2007-2010: What we learned from the largest outbreak ever
P. M. Schneeberger et al.
MEDECINE ET MALADIES INFECTIEUSES (2014)
Characteristics of Hospitalized Acute Q Fever Patients during a Large Epidemic, The Netherlands
Cornelia C. H. Wielders et al.
PLOS ONE (2014)
Persistence of Coxiella burnetii, the Agent of Q Fever, in Murine Adipose Tissue
Yassina Bechah et al.
PLOS ONE (2014)
Exploring the Innate Immunological Response of an Alternative Nonhuman Primate Model of Infectious Disease; the Common Marmoset
M. Nelson et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Human dose response relation for airborne exposure to Coxiella burnetii
Russell John Brooke et al.
BMC INFECTIOUS DISEASES (2013)
Long-Term Immune Responses to Coxiella burnetii after Vaccination
Gilbert J. Kersh et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever
Teske Schoffelen et al.
JOURNAL OF INFECTION (2013)
Economic assessment of Q fever in the Netherlands
M. A. P. M. van Asseldonk et al.
PREVENTIVE VETERINARY MEDICINE (2013)
The 2007-2010 Q fever epidemic in the Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming
Frederika Dijkstra et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)
An animal model that reflects human disease: the common marmoset (Callithrix jacchus)
Ricardo Carrion et al.
CURRENT OPINION IN VIROLOGY (2012)
Identification of Risk Factors for Chronic Q Fever, the Netherlands
Linda M. Kampschreur et al.
EMERGING INFECTIOUS DISEASES (2012)
Isolation from Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth Medium
Anders Omsland et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Undifferentiated Febrile Illnesses Amongst British Troops in Helmand, Afghanistan
M. S. Bailey et al.
JOURNAL OF THE ROYAL ARMY MEDICAL CORPS (2011)
Q Fever among Culling Workers, the Netherlands, 2009-2010
Jane Whelan et al.
EMERGING INFECTIOUS DISEASES (2011)
Real-Time PCR with Serum Samples Is Indispensable for Early Diagnosis of Acute Q Fever
P. M. Schneeberger et al.
Clinical and Vaccine Immunology (2009)
Establishment of lethal inhalational infection with Francisella tularensis (tularaemia) in the common marmoset (Callithrix jacchus)
Michelle Nelson et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Real-time PCR for the early detection and quantification of Coxiella burnetii as an alternative to the murine bioassay
Gerald B. Howe et al.
MOLECULAR AND CELLULAR PROBES (2009)
Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host-implications for post Q fever infection fatigue syndrome and other chronic sequelae
B. P. Marmion et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2009)
Outbreak of Q fever among US military in Western Iraq, june-july 2005
Dennis J. Faix et al.
CLINICAL INFECTIOUS DISEASES (2008)
Coxiella burnetti, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages
Marie Benoit et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Prophylaxis after exposure to Coxiella burnetii
Claire E. Moodie et al.
EMERGING INFECTIOUS DISEASES (2008)
T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice
Masako Andoh et al.
INFECTION AND IMMUNITY (2007)
Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever
K. E. Russell-Lodrigue et al.
INFECTION AND IMMUNITY (2006)
Demand for nonhuman primate resources in the age of biodefense
JL Patterson et al.
ILAR JOURNAL (2005)
Comparison of PCR and serology assays for early diagnosis of acute Q fever
PE Fournier et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Q Fever in Humans and Animals in the United States
Jennifer H. Mcquiston et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2002)
Comparative efficacy and immunogenicity of Q fever chloroform: methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol
DM Waag et al.
VACCINE (2002)
Share Paper
